Table 1 Demographic data and lipid profiles in different BMI groups
From: Obesity, altered oxidative stress, and clinical correlates in chronic schizophrenia patients
Variable | Low BMI group (nā=ā34) | High BMI group (nā=ā55) | F or Ļ2 | df | P-value |
---|---|---|---|---|---|
Age (years) | 51.2ā±ā6.8 | 52.1ā±ā8.7 | 0.272 | 1,87 | 0.603 |
Education (years) | 9.6ā±ā2.5 | 9.8ā±ā2.5 | 0.157 | 1,87 | 0.693 |
Male/female | 26/8 | 34/21 | 2.054 | 1 | 0.171 |
Duration of illness (years) | 27.9ā±ā8.7 | 28.3ā±ā9.5 | 0.054 | 1,87 | 0.816 |
Age of onset (years) | 23.6ā±ā5.7 | 23.6ā±ā6.2 | 0.000 | 1,87 | 0.989 |
Hospitalization numbers | 3.8ā±ā1.9 | 4.0ā±ā3.0 | 0.150 | 1,87 | 0.699 |
BMI (kg/m2) | 21.1ā±ā2.3 | 27.0ā±ā2.2 | 144.9 | 1,87 | 0.000 |
Daily AP dose (mg) (CPZ equivalent) | 338.6ā±ā133.3 | 315.4ā±ā151.0 | 0.541 | 1,87 | 0.464 |
Risperidone/clozapine | 12/22 | 10/45 | 3.306 | 1 | 0.081 |
TG | 1.4ā±ā0.7 | 1.9ā±ā1.1 | 6.557 | 1,86 | 0.012 |
HDL-c | 1.1ā±ā0.1 | 1.1ā±ā0.2 | 2.384 | 1,86 | 0.126 |
LDL-c | 2.8ā±ā0.6 | 3.1ā±ā0.6 | 4.317 | 1,86 | 0.041 |
APOA | 1.2ā±ā0.1 | 1.2ā±ā0.1 | 1.370 | 1,86 | 0.245 |
APOB | 0.7ā±ā0.1 | 0.8ā±ā0.5 | 3.467 | 1,86 | 0.066 |
CHO | 4.3ā±ā0.8 | 4.6ā±ā1.1 | 1.942 | 1,86 | 0.167 |